 908 Devices Inc NASDAQ: MASS is seen as a high-growth life science tools company that analysts at SVB Leerink expect to outperform despite conservative 2021 guidance given by its management due to the current visibility. The 908 Devices Analyst: SV Leerin analyst Puneet Souda has reiterated the 70 price target and maintained his outperform rating on the stock. 